Important notification
20.07.2023 To the attention of interested persons List of training providers with the topic of legislation in the field of […]
Press release
19.07.2023 To the attention of interested persons Reflection paper on the use of artificial intelligence in the lifecycle of medicines […]
Press release
11.07.2023 To the attention of interested persons EMA statement on ongoing review of GLP-1 receptor agonists download document …
Press release
27.06.2023 To the attention of interested persons Withdrawal of application for the marketing authorisation of Lagevrio (molnupiravir) download document …
Press release
23.06.2023 To the attention of interested persons Refusal of the marketing authorisation for Albrioza (sodium phenylbutyrate / ursodoxicoltaurine) download document […]
Important notification
22.06.2023 To the attention of manufacturers, authorised representatives, economic operators and all stakeholders Please be informed that Commission Implementing Regulation […]
Press release
26.05.2023 To the attention of interested persons EMA recommends revocation of authorisation for sickle cell disease medicine Adakveo download document […]
Important notification
19.05.2023 To the attention of manufacturers, authorised representatives, economic operators and all stakeholders Please be advised that on 12 May […]
Press release
12.05.2023 To the attention of interested persons Fluoroquinolone antibiotics: reminder of measures to reduce the risk of long-lasting, disabling and […]
Press release
12.05.2023 To the attention of interested persons Review of hydroxyprogesterone started. download document …